{
  "https://www.natera.com/oncology": "ccd2f43e87e4e8f2f8a5477a18bf0f46ad63d7117e6a850bc2e0f501cadc89ac",
  "https://www.natera.com/company/news": "688f11107fce4d7281e4dae42fe51048cb2091ae6c5c5d9cd385d5f07aab1b64",
  "https://guardanthealth.com/products/tests-for-cancer-screening": "33e88c47f94e40f36d797a8324667689312e4cf4b54726c8eb3c5bb804338880",
  "https://guardanthealth.com/products/tests-for-patients-with-early-and-advanced-stage-cancer": "fa759628ef01a7255b374a3d34eb012998ab1d3724b79b464fcccf4d4e791c5a",
  "https://guardanthealth.com/newsroom/press-releases": "3c6a22baa2fae74e193e2d419e0e14f2e96c65d0dbbc34d384dcc8620c98f26f",
  "https://www.foundationmedicine.com/genomic-testing/foundation-one-cdx": "8a79a20216e5f86be0622adc5a1feda328e3b0eb4076b1d6302c69a2cfb9598d",
  "https://www.foundationmedicine.com/test/foundationone-liquid-cdx": "8104f26789cd25ee1fc03bedcec35376321ee9d50e54a2ea0480802b56f79100",
  "https://www.foundationmedicine.com/press-releases": "3bbb47ab1eafdc3b9a9535607a3e1887fecac1d8f9dc7aad6014d5df486adc3c",
  "https://www.tempus.com/oncology/genomic-profiling": "8d5bffe55dc3e88e71d2f3c8fd36d97703bbe4e49e56f0485d432d2e9e78b2b3",
  "https://www.tempus.com/news": "c22e9cb1128fb18eeda56d8b150091257d33fad6c46b78d3395bff2b1e3270a5",
  "https://www.carislifesciences.com/products-and-services/molecular-profiling": "fcdf3a70497c1ffcb5bc0e012eecf5746c9b9f8fae72dc8f6541869c25c2d39a",
  "https://www.carislifesciences.com/news-and-events/news": "9cb1fbc3c2f9f29988f73f706662f0166ac214388491baaf9bb5b295e9995b3f",
  "https://www.grail.com/galleri": "881bbd1a139b982232360c8dba737ef21771097e49b9ff380d2c02d10e6108bc",
  "https://www.grail.com/press-releases": "e1c332383c6638a86293793f9b49f020d53699083f9140c3d0d8563defc500ba"
}